Status:
COMPLETED
Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function
Lead Sponsor:
Cocco, Giuseppe, M.D.
Collaborating Sponsors:
Cardiology Office, Rheinfelden, Switzerland
Conditions:
Heart Failure
Atrial Fibrillation
Eligibility:
All Genders
60-78 years
Brief Summary
This is an investigator-started study. The trial is coded as no. GC\&PJ-Dig-Iva2009-2012. The authors have no conflict of interest and there was no financial sponsoring The study was planned accordin...
Detailed Description
Selected patients had chronic coronary artery disease which had been treated with percutaneous dilatation \& stenting and/or aortocoronary bypass. The severity of myocardial ischemia had induced heart...
Eligibility Criteria
Inclusion
- No need to change concomitant pharmacological therapy in the following months, dyspnea class III NYHA, and abnormal left ventricular relaxation with preserved (≥52%) left ventricular ejection fraction (LVEF).
Exclusion
- Unstable myocardial ischemia, reduced systolic cardiac function (LVEF\<52%), diabetes mellitus requiring insulin, moderate or severe renal or hepatic dysfunction, or technically insufficient echocardiography.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01796093
Start Date
April 1 2008
End Date
February 1 2012
Last Update
February 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology office
Rheinfelden, Canton of Aargau, Switzerland, CH-4310